RAVULIZUMAB

RAVULIZUMAB was reported 0 times

RAVULIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAKTHROUGH HAEMOLYSIS 177 0.4436
1 EXTRAVASCULAR HAEMOLYSIS 146 0.3435
2 DISSEMINATED GONOCOCCAL INFECTION 6 0.2222
3 TOTAL COMPLEMENT ACTIVITY DECREASED 8 0.1311
4 GONOCOCCAL INFECTION 9 0.1304
5 MENINGOCOCCAL INFECTION 39 0.1234
6 MENINGOCOCCAL SEPSIS 22 0.1158
7 MENINGITIS MENINGOCOCCAL 19 0.1118
8 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 48 0.1023
9 MYASTHENIA GRAVIS CRISIS 141 0.0951
10 NEISSERIA INFECTION 11 0.0866
11 APICAL GRANULOMA 4 0.0667
12 THYMOMA MALIGNANT 5 0.0641
13 MYASTHENIA GRAVIS 511 0.0632
14 MENINGOCOCCAL BACTERAEMIA 6 0.0625
15 NEUROMYELITIS OPTICA SPECTRUM DISORDER 84 0.0623
16 COMPLEMENT FACTOR INCREASED 5 0.0595
17 RETICULOCYTE COUNT INCREASED 45 0.0556
18 HAPTOGLOBIN ABNORMAL 5 0.0543
19 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 43 0.0529
20 HAPTOGLOBIN DECREASED 39 0.0484
21 HAEMOLYSIS 340 0.0440
22 INTRAVASCULAR HAEMOLYSIS 24 0.0429
23 VACCINATION SITE SWELLING 7 0.0407
24 SYMPTOM RECURRENCE 243 0.0406
25 BULBAR PALSY 11 0.0397
26 DROPPED HEAD SYNDROME 15 0.0380
27 COMPLEMENT FACTOR ABNORMAL 4 0.0374
28 VACCINATION SITE PAIN 16 0.0278
29 THYMOMA 10 0.0277
30 EYELID PTOSIS 279 0.0274
31 MASTICATION DISORDER 83 0.0271
32 ENDOTHELIAL DYSFUNCTION 6 0.0259
33 TYPE III IMMUNE COMPLEX MEDIATED REACTION 13 0.0233
34 VACCINATION SITE ERYTHEMA 5 0.0231
35 BLOOD LACTATE DEHYDROGENASE ABNORMAL 15 0.0221
36 VAGUS NERVE DISORDER 5 0.0200
37 SUSPECTED COVID-19 66 0.0200
38 C3 GLOMERULOPATHY 4 0.0193
39 MORAXELLA INFECTION 5 0.0182
40 MUSCLE DISCOMFORT 13 0.0166
41 BUDD-CHIARI SYNDROME 4 0.0158
42 IMMUNISATION REACTION 11 0.0153
43 HAEMOGLOBINURIA 17 0.0152
44 OCULAR MYASTHENIA 5 0.0146
45 VEIN COLLAPSE 11 0.0143
46 DIPLOPIA 367 0.0141
47 POOR VENOUS ACCESS 143 0.0138
48 EXPOSURE VIA BODY FLUID 10 0.0127
49 BLOOD BILIRUBIN UNCONJUGATED INCREASED 9 0.0124
50 BLOOD LACTATE DEHYDROGENASE DECREASED 4 0.0120
51 MUSCLE STRENGTH ABNORMAL 5 0.0119
52 RETICULOCYTE COUNT DECREASED 5 0.0116
53 MUSCLE FATIGUE 48 0.0113
54 SLEEP DEFICIT 23 0.0109
55 BIOPSY BONE MARROW 5 0.0107
56 MENINGITIS 71 0.0106
57 THERAPEUTIC RESPONSE SHORTENED 341 0.0103
58 IRON OVERLOAD 11 0.0102
59 MEAN PLATELET VOLUME DECREASED 8 0.0095
60 RENAL TRANSPLANT 33 0.0091
61 BLOOD LACTATE DEHYDROGENASE INCREASED 144 0.0091
62 MEAN CELL HAEMOGLOBIN INCREASED 15 0.0091
63 INFUSION SITE SCAR 4 0.0090
64 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 7 0.0089
65 HAEMATOMA INFECTION 5 0.0087
66 PNEUMOCOCCAL INFECTION 5 0.0084
67 OPHTHALMOPLEGIA 13 0.0082
68 IMMUNODEFICIENCY COMMON VARIABLE 4 0.0082
69 TONGUE MOVEMENT DISTURBANCE 7 0.0082
70 PNEUMOCOCCAL SEPSIS 5 0.0076
71 SARS-COV-2 TEST NEGATIVE 5 0.0074
72 HAEMATOLOGICAL INFECTION 18 0.0074
73 MARASMUS 11 0.0072
74 BLOOD IRON ABNORMAL 7 0.0072
75 ASTHENOPIA 39 0.0071
76 RENAL TRANSPLANT FAILURE 7 0.0071
77 MENINGITIS BACTERIAL 10 0.0070
78 AMBLYOPIA 4 0.0068
79 APLASTIC ANAEMIA 35 0.0067
80 MEAN CELL VOLUME INCREASED 17 0.0066
81 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 4 0.0065
82 CRITICAL ILLNESS 5 0.0064
83 BLOOD IRON INCREASED 12 0.0064
84 ALTERED VISUAL DEPTH PERCEPTION 5 0.0061
85 PNEUMONIA PSEUDOMONAL 9 0.0059
86 STRABISMUS 16 0.0054
87 CATHETER SITE SWELLING 5 0.0053
88 BASOPHIL COUNT INCREASED 4 0.0053
89 DIAPHRAGMATIC DISORDER 4 0.0052
90 INSURANCE ISSUE 79 0.0052
91 MENINGITIS CRYPTOCOCCAL 9 0.0051
92 DEVICE RELATED THROMBOSIS 5 0.0051
93 VEIN RUPTURE 8 0.0048
94 MUSCULAR WEAKNESS 532 0.0047
95 CRANIOFACIAL FRACTURE 4 0.0047
96 TREATMENT DELAYED 8 0.0046
97 FACIAL PARESIS 16 0.0045
98 THROMBOTIC MICROANGIOPATHY 44 0.0045
99 TEMPERATURE INTOLERANCE 44 0.0043
100 SPINAL CORD DISORDER 7 0.0043
101 HAEMOGLOBIN ABNORMAL 27 0.0042
102 HAEMOGLOBIN DECREASED 423 0.0041
103 PRODUCT PREPARATION ISSUE 27 0.0041
104 LAZINESS 7 0.0041
105 MONOCYTE COUNT DECREASED 5 0.0041
106 PRODUCT TEMPERATURE EXCURSION ISSUE 21 0.0041
107 MENTAL FATIGUE 6 0.0040
108 INTRADUCTAL PROLIFERATIVE BREAST LESION 5 0.0040
109 BRAIN FOG 62 0.0040
110 PHYSICAL DECONDITIONING 10 0.0039
111 MYELITIS 6 0.0039
112 DRUG EFFECT LESS THAN EXPECTED 57 0.0038
113 MUSCULOSKELETAL DISCOMFORT 66 0.0038
114 OESOPHAGEAL SPASM 7 0.0038
115 COLON CANCER METASTATIC 6 0.0037
116 SHOULDER FRACTURE 6 0.0037
117 MENINGITIS VIRAL 5 0.0036
118 NEAR DEATH EXPERIENCE 12 0.0036
119 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
120 TRANSFUSION 37 0.0035
121 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
122 ARTHRITIS BACTERIAL 14 0.0034
123 RED BLOOD CELL COUNT ABNORMAL 5 0.0034
124 SPINAL STENOSIS 14 0.0034
125 APRAXIA 5 0.0034
126 IMMUNE THROMBOCYTOPENIA 15 0.0033
127 INFUSION SITE BRUISING 7 0.0032
128 DYSPHAGIA 304 0.0032
129 STENOSIS 6 0.0032
130 WALKING AID USER 21 0.0032
131 BLEPHAROSPASM 20 0.0032
132 BAND SENSATION 4 0.0032
133 DYSPNOEA AT REST 9 0.0031
134 IMMUNOSUPPRESSION 27 0.0031
135 HAEMOLYTIC URAEMIC SYNDROME 7 0.0030
136 CHROMATURIA 68 0.0030
137 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
138 CENTRAL VENOUS CATHETERISATION 9 0.0030
139 ILLNESS 305 0.0030
140 SLUGGISHNESS 30 0.0029
141 ENTERITIS INFECTIOUS 5 0.0029
142 WHEELCHAIR USER 13 0.0029
143 INFUSION SITE RASH 4 0.0029
144 CHEST INJURY 6 0.0029
145 BLOOD CREATININE ABNORMAL 10 0.0029
146 PHOTOPHOBIA 54 0.0029
147 JOINT INSTABILITY 4 0.0029
148 FRUSTRATION TOLERANCE DECREASED 23 0.0028
149 BLADDER TRANSITIONAL CELL CARCINOMA 4 0.0028
150 PLATELET DISORDER 7 0.0028
151 OCULAR ICTERUS 12 0.0028
152 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
153 LABORATORY TEST ABNORMAL 81 0.0027
154 CHOKING 53 0.0027
155 BODY TEMPERATURE ABNORMAL 5 0.0027
156 BLOOD IRON DECREASED 32 0.0027
157 BACTERAEMIA 32 0.0027
158 AUTOIMMUNE DISORDER 26 0.0027
159 EYE DISORDER 87 0.0026
160 BONE MARROW TRANSPLANT 5 0.0026
161 COMPRESSION FRACTURE 14 0.0026
162 MUSCLE DISORDER 21 0.0026
163 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
164 IMMUNE SYSTEM DISORDER 34 0.0026
165 DYSPNOEA EXERTIONAL 97 0.0026
166 SARS-COV-2 TEST POSITIVE 34 0.0026
167 INFUSION SITE PRURITUS 8 0.0025
168 GENE MUTATION 5 0.0025
169 WEIGHT ABNORMAL 6 0.0025
170 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
171 SPEECH DISORDER 130 0.0025
172 NECK PAIN 138 0.0025
173 ASTHENIA 925 0.0025
174 BACTERIAL SEPSIS 8 0.0025
175 LIMB DISCOMFORT 76 0.0025
176 RENAL MASS 5 0.0024
177 IMMUNODEFICIENCY 36 0.0024
178 IGA NEPHROPATHY 4 0.0024
179 DYSARTHRIA 90 0.0024
180 WALKING DISABILITY 5 0.0024
181 NERVE COMPRESSION 22 0.0024
182 URINARY TRACT INFECTION BACTERIAL 6 0.0024
183 JAW DISORDER 13 0.0024
184 OPTIC NEUROPATHY 5 0.0024
185 ATYPICAL PNEUMONIA 7 0.0023
186 FATIGUE 1819 0.0023
187 RETINAL DISORDER 6 0.0023
188 KIDNEY TRANSPLANT REJECTION 11 0.0023
189 DYSAESTHESIA 7 0.0023
190 SERUM FERRITIN INCREASED 12 0.0023
191 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
192 OVERWEIGHT 12 0.0022
193 INFECTIOUS MONONUCLEOSIS 5 0.0022
194 FUNGAL SKIN INFECTION 9 0.0022
195 MENINGITIS ASEPTIC 10 0.0022
196 HYPERVOLAEMIA 11 0.0022
197 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
198 HEAD DISCOMFORT 39 0.0022
199 BILE DUCT STONE 7 0.0022
200 SPONDYLITIS 8 0.0022
201 ORTHOPNOEA 7 0.0022
202 BLOOD PHOSPHORUS INCREASED 6 0.0022
203 BLOOD BILIRUBIN INCREASED 59 0.0022
204 CEREBRAL THROMBOSIS 6 0.0021
205 PERONEAL NERVE PALSY 12 0.0021
206 OPTIC NEURITIS 19 0.0021
207 VITAMIN B12 DECREASED 6 0.0021
208 INFUSION SITE SWELLING 13 0.0021
209 RHINOVIRUS INFECTION 8 0.0021
210 LUMBAR SPINAL STENOSIS 6 0.0021
211 INFUSION SITE REACTION 6 0.0020
212 EYELID IRRITATION 5 0.0020
213 SYSTEMIC CANDIDA 5 0.0020
214 DEVICE RELATED SEPSIS 4 0.0020
215 MYELOFIBROSIS 6 0.0020
216 HAEMOGLOBIN INCREASED 9 0.0020
217 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
218 PNEUMONIA BACTERIAL 18 0.0020
219 DECREASED IMMUNE RESPONSIVENESS 19 0.0019
220 THERAPY CHANGE 19 0.0019
221 BLOOD TEST ABNORMAL 27 0.0019
222 BLOOD CREATININE DECREASED 6 0.0019
223 DIVERTICULITIS 53 0.0019
224 EYE CONTUSION 4 0.0019
225 OROPHARYNGEAL DISCOMFORT 17 0.0019
226 INTERVERTEBRAL DISC DISORDER 8 0.0019
227 TRANSPLANT REJECTION 15 0.0019
228 BALANCE DISORDER 161 0.0019
229 BREAST SWELLING 5 0.0019
230 AMYOTROPHIC LATERAL SCLEROSIS 4 0.0019
231 EXPOSURE DURING PREGNANCY 115 0.0018
232 MUSCLE STRAIN 16 0.0018
233 DYSSTASIA 53 0.0018
234 RED BLOOD CELL COUNT INCREASED 5 0.0018
235 VEIN DISORDER 9 0.0018
236 LOWER RESPIRATORY TRACT INFECTION 81 0.0018
237 INFUSION SITE EXTRAVASATION 11 0.0018
238 PSEUDOMONAS INFECTION 15 0.0017
239 LOCALISED INFECTION 42 0.0017
240 HYPERTONIC BLADDER 5 0.0017
241 MYELODYSPLASTIC SYNDROME 25 0.0017
242 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
243 ESCHERICHIA SEPSIS 5 0.0017
244 BODY TEMPERATURE INCREASED 35 0.0017
245 HAEMATOCRIT DECREASED 34 0.0017
246 TRIGGER FINGER 7 0.0017
247 DISCOURAGEMENT 4 0.0017
248 GRIP STRENGTH DECREASED 15 0.0017
249 ESCHERICHIA BACTERAEMIA 4 0.0017
250 BACK PAIN 395 0.0017
251 BRADYKINESIA 10 0.0017
252 DYSPHONIA 99 0.0017
253 VIRAL INFECTION 56 0.0017
254 INFUSION RELATED REACTION 111 0.0017
255 ANAL INCONTINENCE 15 0.0017
256 URINARY TRACT INFECTION 284 0.0017
257 PLATELET COUNT ABNORMAL 10 0.0017
258 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
259 POOR PERIPHERAL CIRCULATION 7 0.0016
260 DEAFNESS UNILATERAL 9 0.0016
261 METASTATIC NEOPLASM 7 0.0016
262 PYELONEPHRITIS 14 0.0016
263 INFECTION 233 0.0016
264 BACTERIAL INFECTION 30 0.0016
265 OCULAR DISCOMFORT 18 0.0016
266 DIVERTICULUM INTESTINAL 7 0.0016
267 INFLUENZA 178 0.0016
268 FEELING ABNORMAL 379 0.0016
269 MUSCLE ATROPHY 20 0.0016
270 ABDOMINAL INFECTION 4 0.0016
271 CATARACT 93 0.0016
272 BLOOD URIC ACID INCREASED 9 0.0016
273 INFUSION SITE PAIN 20 0.0016
274 SYSTEMIC LUPUS ERYTHEMATOSUS 55 0.0015
275 TRISMUS 8 0.0015
276 MUSCLE TIGHTNESS 25 0.0015
277 PLATELET COUNT DECREASED 164 0.0015
278 ORAL INFECTION 6 0.0015
279 COVID-19 269 0.0015
280 UROSEPSIS 14 0.0015
281 UPPER RESPIRATORY TRACT INFECTION 70 0.0015
282 ARTHRITIS INFECTIVE 7 0.0015
283 RED BLOOD CELL COUNT DECREASED 43 0.0015
284 ROSACEA 7 0.0015
285 HYPERSOMNIA 43 0.0015
286 BLOOD DISORDER 12 0.0015
287 YELLOW SKIN 7 0.0015
288 GAIT DISTURBANCE 286 0.0015
289 JAUNDICE 40 0.0015
290 BLOOD SODIUM INCREASED 4 0.0015
291 GAIT INABILITY 49 0.0015
292 CLUMSINESS 4 0.0015
293 NASOPHARYNGITIS 267 0.0014
294 CHOLECYSTITIS INFECTIVE 4 0.0014
295 FULL BLOOD COUNT ABNORMAL 15 0.0014
296 RENAL PAIN 15 0.0014
297 JOINT LOCK 4 0.0014
298 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
299 SCIATICA 22 0.0014
300 SCLERODERMA 5 0.0014
301 CUTANEOUS VASCULITIS 5 0.0014
302 GENERAL PHYSICAL HEALTH DETERIORATION 158 0.0014
303 LIGAMENT RUPTURE 6 0.0014
304 VISUAL IMPAIRMENT 168 0.0014
305 NEPHROLITHIASIS 62 0.0014
306 HYPERACUSIS 5 0.0013
307 HAEMOLYTIC ANAEMIA 12 0.0013
308 URINARY TRACT DISORDER 6 0.0013
309 SENSITIVITY TO WEATHER CHANGE 7 0.0013
310 PARANASAL SINUS DISCOMFORT 5 0.0013
311 RESTLESS LEGS SYNDROME 24 0.0013
312 END STAGE RENAL DISEASE 24 0.0013
313 LIGAMENT SPRAIN 13 0.0013
314 DROOLING 9 0.0013
315 DECREASED ACTIVITY 14 0.0013
316 RENAL FUNCTION TEST ABNORMAL 6 0.0013
317 BACK DISORDER 21 0.0013
318 REHABILITATION THERAPY 5 0.0013
319 FULL BLOOD COUNT DECREASED 26 0.0013
320 APPENDICITIS 12 0.0013
321 UMBILICAL HERNIA 6 0.0013
322 CELLULITIS 64 0.0013
323 BLOOD URINE PRESENT 24 0.0013
324 CHOLECYSTITIS 15 0.0013
325 HYPERTENSIVE CRISIS 14 0.0013
326 STREPTOCOCCAL INFECTION 7 0.0013
327 BLOOD PRESSURE ABNORMAL 25 0.0013
328 MUSCULOSKELETAL STIFFNESS 110 0.0013
329 VITAMIN B12 DEFICIENCY 5 0.0012
330 IMPAIRED DRIVING ABILITY 14 0.0012
331 HEADACHE 772 0.0012
332 LYMPHOMA 19 0.0012
333 HEPATIC NEOPLASM 4 0.0012
334 HEAVY MENSTRUAL BLEEDING 11 0.0012
335 DEMYELINATION 5 0.0012
336 GASTROENTERITIS VIRAL 22 0.0012
337 ESCHERICHIA INFECTION 10 0.0012
338 STAPHYLOCOCCAL SEPSIS 6 0.0012
339 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
340 BLINDNESS 49 0.0012
341 DIALYSIS 17 0.0012
342 SPINAL PAIN 14 0.0012
343 SEPSIS 133 0.0012
344 COVID-19 PNEUMONIA 14 0.0012
345 MACULAR DEGENERATION 14 0.0012
346 MUSCLE TWITCHING 27 0.0012
347 DIABETES MELLITUS 89 0.0012
348 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
349 TENSION HEADACHE 5 0.0012
350 BLOOD MAGNESIUM DECREASED 10 0.0012
351 RENAL IMPAIRMENT 97 0.0012
352 TOOTH INJURY 5 0.0012
353 SPINAL FRACTURE 23 0.0011
354 WEIGHT FLUCTUATION 12 0.0011
355 APHONIA 16 0.0011
356 DEMENTIA 32 0.0011
357 GLAUCOMA 22 0.0011
358 COLON CANCER 17 0.0011
359 BLINDNESS UNILATERAL 16 0.0011
360 ANAEMIA 215 0.0011
361 BLOOD CREATININE INCREASED 73 0.0011
362 SENSORY LOSS 9 0.0011
363 MOBILITY DECREASED 80 0.0011
364 PROTEINURIA 21 0.0011
365 OSTEOMYELITIS 20 0.0011
366 VASCULAR DEVICE INFECTION 5 0.0011
367 HYPOKINESIA 16 0.0011
368 MALAISE 483 0.0011
369 WOUND INFECTION 12 0.0011
370 ASPIRATION 12 0.0011
371 MUSCLE SPASMS 201 0.0011
372 RENAL DISORDER 51 0.0011
373 LUMBAR VERTEBRAL FRACTURE 5 0.0011
374 TASTE DISORDER 22 0.0011
375 EOSINOPHIL COUNT INCREASED 9 0.0011
376 ARTHROPOD BITE 8 0.0011
377 HERPES ZOSTER 62 0.0011
378 LYMPHOCYTE COUNT DECREASED 19 0.0011
379 BLOOD PRESSURE INCREASED 164 0.0011
380 RESPIRATORY DISORDER 32 0.0011
381 NEURALGIA 26 0.0011
382 THROMBOSIS 86 0.0011
383 CYSTITIS 34 0.0011
384 FLANK PAIN 10 0.0011
385 GALLBLADDER DISORDER 19 0.0011
386 CATHETER SITE INFECTION 4 0.0011
387 FACIAL PARALYSIS 9 0.0011
388 FACE INJURY 4 0.0011
389 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
390 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
391 SKIN MASS 7 0.0010
392 PARALYSIS 15 0.0010
393 SUBCUTANEOUS ABSCESS 5 0.0010
394 HEAD INJURY 33 0.0010
395 COLITIS ISCHAEMIC 7 0.0010
396 ATRIAL FIBRILLATION 101 0.0010
397 SEPTIC SHOCK 45 0.0010
398 EATING DISORDER 22 0.0010
399 PULMONARY HAEMORRHAGE 8 0.0010
400 KIDNEY INFECTION 20 0.0010
401 RESPIRATION ABNORMAL 7 0.0010
402 VISION BLURRED 139 0.0010
403 LYMPHOEDEMA 7 0.0010
404 LARGE INTESTINE POLYP 7 0.0010
405 PULMONARY THROMBOSIS 11 0.0010
406 LARGE INTESTINE PERFORATION 7 0.0010
407 RENAL CYST 8 0.0010
408 EXPOSURE VIA BREAST MILK 4 0.0010
409 NEOPLASM MALIGNANT 67 0.0010
410 RESPIRATORY TRACT INFECTION 26 0.0010
411 ERYSIPELAS 5 0.0010
412 LIMB INJURY 27 0.0010
413 INGUINAL HERNIA 6 0.0010
414 DECUBITUS ULCER 8 0.0010
415 PRODUCT SUPPLY ISSUE 7 0.0010
416 HYPOACUSIS 42 0.0010
417 ENDOCARDITIS 5 0.0010
418 THYROID DISORDER 15 0.0010
419 DYSPNOEA 548 0.0010
420 TONGUE DISORDER 7 0.0010
421 AORTIC DISSECTION 4 0.0010
422 MYALGIA 162 0.0010
423 ISCHAEMIC STROKE 17 0.0010
424 SPINAL DISORDER 9 0.0009
425 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
426 GINGIVITIS 5 0.0009
427 MYOPATHY 8 0.0009
428 LETHARGY 53 0.0009
429 ACCIDENT 11 0.0009
430 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
431 CHOLELITHIASIS 30 0.0009
432 HYPOGAMMAGLOBULINAEMIA 6 0.0009
433 SPINAL OSTEOARTHRITIS 8 0.0009
434 FALL 303 0.0009
435 CORONAVIRUS INFECTION 6 0.0009
436 FOOD ALLERGY 7 0.0009
437 ABDOMINAL ABSCESS 4 0.0009
438 BLOOD CREATINE INCREASED 4 0.0009
439 ARTHRITIS 71 0.0009
440 PRODUCTIVE COUGH 43 0.0009
441 NERVE INJURY 10 0.0009
442 EYE HAEMORRHAGE 12 0.0009
443 CYTOPENIA 11 0.0009
444 FACIAL PAIN 8 0.0009
445 MALIGNANT MELANOMA 12 0.0009
446 QUALITY OF LIFE DECREASED 12 0.0009
447 SKIN INFECTION 10 0.0009
448 ACUTE PULMONARY OEDEMA 5 0.0009
449 IRON DEFICIENCY 4 0.0009
450 POSTOPERATIVE WOUND INFECTION 6 0.0009
451 FEEDING DISORDER 18 0.0009
452 PHARYNGITIS 11 0.0009
453 CYST 11 0.0009
454 PAIN IN EXTREMITY 260 0.0009
455 ABSCESS 14 0.0009
456 EYE MOVEMENT DISORDER 6 0.0009
457 CARDIAC VALVE DISEASE 5 0.0009
458 BRAIN NEOPLASM 8 0.0009
459 ISCHAEMIA 4 0.0009
460 HERPES VIRUS INFECTION 5 0.0009
461 ENCEPHALITIS 6 0.0009
462 IRON DEFICIENCY ANAEMIA 8 0.0009
463 ENTEROCOLITIS 5 0.0009
464 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
465 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
466 SOMNOLENCE 173 0.0009
467 MIGRAINE 82 0.0009
468 SINUS DISORDER 17 0.0009
469 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
470 HICCUPS 7 0.0009
471 PNEUMONIA 276 0.0009
472 RHINORRHOEA 55 0.0009
473 SEASONAL ALLERGY 12 0.0008
474 THERAPY NON-RESPONDER 38 0.0008
475 MEMORY IMPAIRMENT 116 0.0008
476 HYPOAESTHESIA 126 0.0008
477 PNEUMONIA ASPIRATION 21 0.0008
478 ENDOMETRIOSIS 4 0.0008
479 BLOOD UREA INCREASED 14 0.0008
480 POOR QUALITY SLEEP 18 0.0008
481 PERIPHERAL SWELLING 128 0.0008
482 ENTEROCOCCAL INFECTION 4 0.0008
483 PRODUCT PREPARATION ERROR 17 0.0008
484 DIZZINESS POSTURAL 8 0.0008
485 GASTROENTERITIS 12 0.0008
486 PHARYNGEAL SWELLING 8 0.0008
487 PYREXIA 282 0.0008
488 MENISCUS INJURY 5 0.0008
489 BLOOD POTASSIUM INCREASED 13 0.0008
490 JOINT STIFFNESS 21 0.0008
491 CONTUSION 77 0.0008
492 NEUROPATHY PERIPHERAL 76 0.0008
493 SECRETION DISCHARGE 10 0.0008
494 CORONARY ARTERY STENOSIS 4 0.0008
495 ARTHRALGIA 330 0.0008
496 FRACTURE 15 0.0008
497 FEELING COLD 22 0.0008
498 INTERNAL HAEMORRHAGE 9 0.0008
499 DEATH 677 0.0008
500 BLOOD PRESSURE DECREASED 52 0.0008
501 PROCEDURAL COMPLICATION 6 0.0008
502 GASTROINTESTINAL INFECTION 7 0.0008
503 FEMORAL NECK FRACTURE 4 0.0008
504 INCREASED UPPER AIRWAY SECRETION 4 0.0008
505 OROPHARYNGEAL PAIN 72 0.0008
506 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
507 URINARY INCONTINENCE 23 0.0008
508 HERNIA 15 0.0008
509 CONCUSSION 6 0.0008
510 ABORTION SPONTANEOUS 31 0.0008
511 CARDIAC FLUTTER 5 0.0008
512 INCOHERENT 5 0.0008
513 CHEST DISCOMFORT 79 0.0008
514 PETECHIAE 8 0.0008
515 BLOOD POTASSIUM DECREASED 23 0.0008
516 DEAFNESS 20 0.0008
517 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
518 APHASIA 23 0.0008
519 WEIGHT DECREASED 212 0.0008
520 DYSGRAPHIA 5 0.0008
521 PULMONARY CONGESTION 10 0.0008
522 STAPHYLOCOCCAL INFECTION 25 0.0008
523 JOINT DISLOCATION 8 0.0008
524 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
525 JOINT INJURY 16 0.0007
526 POST-TRAUMATIC STRESS DISORDER 5 0.0007
527 BREAST MASS 5 0.0007
528 CHILLS 87 0.0007
529 LEUKAEMIA 7 0.0007
530 POST PROCEDURAL INFECTION 6 0.0007
531 GASTROINTESTINAL DISORDER 66 0.0007
532 PAIN 452 0.0007
533 PERICARDIAL EFFUSION 17 0.0007
534 HYDROCEPHALUS 4 0.0007
535 SINUSITIS 75 0.0007
536 NASAL CONGESTION 43 0.0007
537 SMALL INTESTINAL OBSTRUCTION 9 0.0007
538 POST PROCEDURAL COMPLICATION 14 0.0007
539 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 35 0.0007
540 LACRIMATION INCREASED 22 0.0007
541 GENERALISED OEDEMA 9 0.0007
542 THERAPEUTIC RESPONSE DECREASED 44 0.0007
543 CHOKING SENSATION 4 0.0007
544 HYPERKERATOSIS 4 0.0007
545 MUSCLE INJURY 6 0.0007
546 EMBOLISM 6 0.0007
547 HEMIPLEGIA 6 0.0007
548 FUNGAL INFECTION 24 0.0007
549 HIP FRACTURE 23 0.0007
550 DEVICE RELATED INFECTION 11 0.0007
551 CARPAL TUNNEL SYNDROME 10 0.0007
552 ANGIOPATHY 4 0.0007
553 SNEEZING 16 0.0007
554 INTESTINAL PERFORATION 8 0.0007
555 ANKLE FRACTURE 11 0.0007
556 CANDIDA INFECTION 12 0.0007
557 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
558 ABDOMINAL DISCOMFORT 119 0.0007
559 BASAL CELL CARCINOMA 11 0.0007
560 BLADDER DISORDER 7 0.0007
561 BLOOD GLUCOSE ABNORMAL 13 0.0007
562 UPPER LIMB FRACTURE 14 0.0007
563 BRONCHITIS 52 0.0007
564 SCAR 12 0.0007
565 NEOPLASM 8 0.0007
566 EXERCISE TOLERANCE DECREASED 4 0.0007
567 PANIC REACTION 5 0.0007
568 HYPERVENTILATION 4 0.0007
569 SUBARACHNOID HAEMORRHAGE 7 0.0007
570 POST PROCEDURAL HAEMORRHAGE 8 0.0007
571 MOVEMENT DISORDER 22 0.0007
572 SPLENOMEGALY 8 0.0007
573 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
574 SLEEP APNOEA SYNDROME 13 0.0007
575 CHEST PAIN 126 0.0007
576 WOUND 19 0.0007
577 CEREBROVASCULAR ACCIDENT 115 0.0007
578 DECREASED INTEREST 4 0.0007
579 EAR INFECTION 18 0.0007
580 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
581 CEREBRAL DISORDER 5 0.0007
582 PULMONARY MASS 10 0.0007
583 CARDIAC PACEMAKER INSERTION 4 0.0007
584 ANAPHYLACTIC REACTION 37 0.0007
585 OFF LABEL USE 581 0.0007
586 DEPRESSED MOOD 35 0.0007
587 SUDDEN DEATH 7 0.0007
588 COUGH 185 0.0007
589 BONE DISORDER 12 0.0007
590 CONDITION AGGRAVATED 200 0.0007
591 EXOSTOSIS 6 0.0007
592 BREAST PAIN 7 0.0007
593 PROCEDURAL PAIN 18 0.0006
594 BONE PAIN 38 0.0006
595 PHARYNGITIS STREPTOCOCCAL 7 0.0006
596 MUSCULOSKELETAL CHEST PAIN 10 0.0006
597 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
598 MASS 9 0.0006
599 SKIN LACERATION 7 0.0006
600 NEUTROPHIL COUNT DECREASED 26 0.0006
601 TOOTH FRACTURE 7 0.0006
602 COLITIS 24 0.0006
603 RIB FRACTURE 13 0.0006
604 LIVER DISORDER 28 0.0006
605 LOW BIRTH WEIGHT BABY 5 0.0006
606 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
607 COLD SWEAT 11 0.0006
608 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
609 PANCREATITIS ACUTE 14 0.0006
610 RHINITIS 5 0.0006
611 WEIGHT INCREASED 138 0.0006
612 HERPES SIMPLEX 4 0.0006
613 HAEMATURIA 21 0.0006
614 HOSPICE CARE 6 0.0006
615 VERTIGO 37 0.0006
616 TOOTH INFECTION 8 0.0006
617 DISABILITY 12 0.0006
618 SEIZURE 70 0.0006
619 PHOTOSENSITIVITY REACTION 10 0.0006
620 APPETITE DISORDER 4 0.0006
621 HEART RATE DECREASED 21 0.0006
622 MENTAL DISORDER 26 0.0006
623 DIZZINESS 297 0.0006
624 TYPE 2 DIABETES MELLITUS 20 0.0006
625 BLOOD COUNT ABNORMAL 9 0.0006
626 THROAT TIGHTNESS 16 0.0006
627 BONE MARROW FAILURE 12 0.0006
628 NIGHT SWEATS 19 0.0006
629 DRUG INEFFECTIVE 775 0.0006
630 NEUTROPHIL COUNT INCREASED 6 0.0006
631 HEPATIC CIRRHOSIS 11 0.0006
632 VITAMIN D DECREASED 5 0.0006
633 BLOOD SODIUM DECREASED 11 0.0006
634 CORONARY ARTERY OCCLUSION 8 0.0006
635 PERIPHERAL COLDNESS 8 0.0006
636 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
637 FEMUR FRACTURE 18 0.0006
638 CARDIAC MURMUR 5 0.0006
639 ORAL DISCOMFORT 8 0.0006
640 NERVOUSNESS 30 0.0006
641 DISCOMFORT 35 0.0006
642 LUNG DISORDER 28 0.0006
643 FEELING HOT 35 0.0006
644 FLUID RETENTION 29 0.0006
645 DIARRHOEA 368 0.0006
646 LOSS OF CONSCIOUSNESS 73 0.0006
647 GROIN PAIN 5 0.0006
648 INCONTINENCE 6 0.0006
649 SWELLING 53 0.0006
650 ULCER 9 0.0006
651 LYMPHOPENIA 8 0.0006
652 HEART RATE INCREASED 56 0.0006
653 PREMATURE DELIVERY 9 0.0006
654 HAND FRACTURE 4 0.0006
655 HAEMORRHOIDS 11 0.0006
656 DIVERTICULUM 4 0.0006
657 LUNG NEOPLASM MALIGNANT 23 0.0006
658 INFLUENZA LIKE ILLNESS 46 0.0006
659 ARTHROPATHY 31 0.0006
660 SKIN CANCER 12 0.0006
661 GRAFT VERSUS HOST DISEASE 4 0.0006
662 BACK INJURY 6 0.0006
663 PALLOR 15 0.0006
664 CARDIAC DISORDER 51 0.0005
665 ROTATOR CUFF SYNDROME 7 0.0005
666 RETINAL DETACHMENT 5 0.0005
667 INCREASED TENDENCY TO BRUISE 5 0.0005
668 ABDOMINAL PAIN 126 0.0005
669 PRODUCT DISTRIBUTION ISSUE 5 0.0005
670 DEEP VEIN THROMBOSIS 35 0.0005
671 PLATELET COUNT INCREASED 7 0.0005
672 PRESYNCOPE 13 0.0005
673 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
674 PERITONITIS 11 0.0005
675 CEREBRAL HAEMORRHAGE 19 0.0005
676 FOOT FRACTURE 10 0.0005
677 PULMONARY EMBOLISM 50 0.0005
678 DERMATITIS CONTACT 6 0.0005
679 SCAB 6 0.0005
680 ROAD TRAFFIC ACCIDENT 22 0.0005
681 AORTIC ANEURYSM 4 0.0005
682 SLEEP DISORDER 37 0.0005
683 PRODUCT DOSE OMISSION ISSUE 154 0.0005
684 ACIDOSIS 4 0.0005
685 BOWEL MOVEMENT IRREGULARITY 4 0.0005
686 PANIC ATTACK 19 0.0005
687 RESPIRATORY FAILURE 38 0.0005
688 ABDOMINAL PAIN UPPER 107 0.0005
689 THROMBOCYTOPENIA 58 0.0005
690 SINUS CONGESTION 7 0.0005
691 INSOMNIA 138 0.0005
692 OSTEONECROSIS 17 0.0005
693 HOT FLUSH 39 0.0005
694 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
695 APHTHOUS ULCER 4 0.0005
696 EAR PAIN 10 0.0005
697 BURNING SENSATION 36 0.0005
698 NERVOUS SYSTEM DISORDER 16 0.0005
699 TREMOR 84 0.0005
700 DISEASE RECURRENCE 24 0.0005
701 BLOOD ALBUMIN DECREASED 4 0.0005
702 OVARIAN CYST 5 0.0005
703 THYROID CANCER 6 0.0005
704 EMPHYSEMA 5 0.0005
705 MENTAL IMPAIRMENT 12 0.0005
706 CONFUSIONAL STATE 80 0.0005
707 INFLAMMATION 25 0.0005
708 HYPERTHYROIDISM 7 0.0005
709 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 87 0.0005
710 HYPERBILIRUBINAEMIA 5 0.0005
711 HEPATIC FUNCTION ABNORMAL 18 0.0005
712 APATHY 7 0.0005
713 PERICARDITIS 8 0.0005
714 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
715 INFUSION SITE ERYTHEMA 4 0.0005
716 PARAESTHESIA 74 0.0005
717 LOWER LIMB FRACTURE 9 0.0005
718 THROAT IRRITATION 21 0.0005
719 IMPAIRED WORK ABILITY 10 0.0005
720 ANURIA 4 0.0005
721 HYPOAESTHESIA ORAL 7 0.0005
722 OXYGEN SATURATION DECREASED 26 0.0005
723 OSTEOPOROSIS 19 0.0005
724 DYSURIA 17 0.0005
725 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
726 BIPOLAR DISORDER 5 0.0005
727 BLOOD PRESSURE FLUCTUATION 11 0.0005
728 HYPERHIDROSIS 59 0.0005
729 BEDRIDDEN 6 0.0005
730 BLOOD CALCIUM INCREASED 4 0.0005
731 ANXIETY 129 0.0005
732 FLUSHING 46 0.0005
733 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
734 SYNCOPE 45 0.0004
735 THERAPY PARTIAL RESPONDER 7 0.0004
736 GOUT 8 0.0004
737 FISTULA 5 0.0004
738 RENAL FAILURE 59 0.0004
739 HYPERTENSION 94 0.0004
740 HEART RATE IRREGULAR 10 0.0004
741 NAUSEA 350 0.0004
742 MITRAL VALVE INCOMPETENCE 5 0.0004
743 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
744 RESPIRATORY TRACT CONGESTION 7 0.0004
745 IMPAIRED GASTRIC EMPTYING 6 0.0004
746 TINNITUS 20 0.0004
747 PANCREATITIS 23 0.0004
748 DELIRIUM 15 0.0004
749 COORDINATION ABNORMAL 6 0.0004
750 HOSPITALISATION 66 0.0004
751 HEPATIC STEATOSIS 8 0.0004
752 VASCULITIS 5 0.0004
753 MOUTH ULCERATION 9 0.0004
754 DYSPEPSIA 42 0.0004
755 ARTERIOSCLEROSIS 4 0.0004
756 ALOPECIA 83 0.0004
757 RETCHING 9 0.0004
758 COAGULOPATHY 7 0.0004
759 LIVER FUNCTION TEST INCREASED 9 0.0004
760 SUBDURAL HAEMATOMA 6 0.0004
761 PARAESTHESIA ORAL 6 0.0004
762 ATELECTASIS 4 0.0004
763 HEMIPARESIS 7 0.0004
764 CARDIAC FAILURE 33 0.0004
765 EYE PAIN 23 0.0004
766 DEHYDRATION 54 0.0004
767 DISORIENTATION 16 0.0004
768 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
769 PULMONARY OEDEMA 18 0.0004
770 EPISTAXIS 30 0.0004
771 OSTEOARTHRITIS 17 0.0004
772 PRODUCT ADMINISTRATION ERROR 8 0.0004
773 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
774 HYPOPHAGIA 10 0.0004
775 EAR DISCOMFORT 4 0.0004
776 URINARY RETENTION 13 0.0004
777 EMOTIONAL DISORDER 12 0.0004
778 BREAST CANCER 36 0.0004
779 VOMITING 181 0.0004
780 MYOCARDIAL INFARCTION 67 0.0004
781 HAEMORRHAGE 40 0.0004
782 CONJUNCTIVITIS 7 0.0004
783 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
784 HYPERSENSITIVITY 70 0.0004
785 HYPOTHYROIDISM 12 0.0004
786 HEPATIC CANCER 9 0.0004
787 BLISTER 21 0.0004
788 PROSTATE CANCER 30 0.0004
789 JOINT RANGE OF MOTION DECREASED 5 0.0004
790 ACUTE KIDNEY INJURY 57 0.0004
791 DECREASED APPETITE 86 0.0004
792 SKIN DISCOLOURATION 17 0.0004
793 SWELLING FACE 24 0.0004
794 CEREBRAL INFARCTION 9 0.0004
795 MUSCULOSKELETAL DISORDER 7 0.0004
796 COGNITIVE DISORDER 17 0.0004
797 GASTROINTESTINAL PAIN 4 0.0004
798 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
799 AGEUSIA 9 0.0004
800 HAEMOPTYSIS 10 0.0004
801 RASH 156 0.0004
802 PANCYTOPENIA 20 0.0004
803 C-REACTIVE PROTEIN INCREASED 13 0.0004
804 BLOOD CALCIUM DECREASED 4 0.0004
805 SKIN REACTION 5 0.0004
806 EYE INFECTION 4 0.0004
807 HEPATIC ENZYME INCREASED 24 0.0004
808 DRUG INTOLERANCE 34 0.0004
809 OEDEMA 19 0.0003
810 EYE SWELLING 13 0.0003
811 CARDIAC FAILURE CONGESTIVE 28 0.0003
812 SKIN ULCER 9 0.0003
813 URTICARIA 58 0.0003
814 INTESTINAL OBSTRUCTION 13 0.0003
815 ORTHOSTATIC HYPOTENSION 6 0.0003
816 METABOLIC ACIDOSIS 11 0.0003
817 METASTASES TO LIVER 6 0.0003
818 LEUKOPENIA 17 0.0003
819 CARDIOMYOPATHY 5 0.0003
820 POLLAKIURIA 14 0.0003
821 IMPAIRED HEALING 11 0.0003
822 FEAR 9 0.0003
823 FREQUENT BOWEL MOVEMENTS 9 0.0003
824 IRRITABILITY 20 0.0003
825 ADRENAL INSUFFICIENCY 4 0.0003
826 OSTEOPENIA 5 0.0003
827 FIBROMYALGIA 8 0.0003
828 RECTAL HAEMORRHAGE 14 0.0003
829 MUSCULOSKELETAL PAIN 17 0.0003
830 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
831 TENDONITIS 5 0.0003
832 THINKING ABNORMAL 6 0.0003
833 SWOLLEN TONGUE 10 0.0003
834 ASTHMA 36 0.0003
835 PNEUMOTHORAX 5 0.0003
836 INCREASED APPETITE 6 0.0003
837 OBESITY 5 0.0003
838 RASH PRURITIC 17 0.0003
839 BLOOD GLUCOSE DECREASED 15 0.0003
840 PLEURAL EFFUSION 19 0.0003
841 DEPRESSION 71 0.0003
842 ACUTE RESPIRATORY FAILURE 6 0.0003
843 PANCREATIC CARCINOMA 9 0.0003
844 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
845 ASCITES 9 0.0003
846 TACHYCARDIA 27 0.0003
847 VENTRICULAR TACHYCARDIA 5 0.0003
848 ADVERSE REACTION 4 0.0003
849 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
850 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
851 CYTOMEGALOVIRUS INFECTION 5 0.0003
852 HAIR TEXTURE ABNORMAL 4 0.0003
853 HEPATIC FAILURE 9 0.0003
854 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
855 DISTURBANCE IN ATTENTION 16 0.0003
856 OCULAR HYPERAEMIA 14 0.0003
857 AMNESIA 19 0.0003
858 PRURITUS 112 0.0003
859 DIABETIC KETOACIDOSIS 7 0.0003
860 CARDIAC ARREST 24 0.0003
861 PALPITATIONS 34 0.0003
862 ABDOMINAL DISTENSION 30 0.0003
863 DEVICE OCCLUSION 4 0.0003
864 DRUG ERUPTION 5 0.0003
865 BLOOD GLUCOSE INCREASED 53 0.0003
866 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
867 DRY EYE 14 0.0003
868 THIRST 5 0.0003
869 IMPAIRED QUALITY OF LIFE 4 0.0003
870 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
871 ABDOMINAL PAIN LOWER 7 0.0003
872 FAECES DISCOLOURED 6 0.0003
873 HAEMATEMESIS 7 0.0003
874 TREATMENT NONCOMPLIANCE 15 0.0003
875 JOINT SWELLING 33 0.0003
876 RHEUMATOID ARTHRITIS 31 0.0003
877 ADVERSE EVENT 25 0.0003
878 STEVENS-JOHNSON SYNDROME 6 0.0003
879 TOOTH DISORDER 6 0.0003
880 ERYTHEMA 55 0.0003
881 HAEMORRHAGE INTRACRANIAL 4 0.0003
882 GASTRITIS 7 0.0003
883 THERAPY INTERRUPTED 19 0.0003
884 PREMATURE BABY 8 0.0003
885 ILL-DEFINED DISORDER 16 0.0003
886 OEDEMA PERIPHERAL 32 0.0003
887 SHOCK 6 0.0003
888 HYPOTENSION 52 0.0003
889 DYSTONIA 5 0.0003
890 BLOOD CHOLESTEROL INCREASED 12 0.0003
891 ACUTE MYELOID LEUKAEMIA 4 0.0003
892 INJURY 18 0.0003
893 SKIN LESION 7 0.0003
894 CYANOSIS 4 0.0003
895 CHRONIC KIDNEY DISEASE 19 0.0002
896 CRYING 9 0.0002
897 CONSTIPATION 54 0.0002
898 PAIN IN JAW 7 0.0002
899 DYSKINESIA 10 0.0002
900 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
901 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
902 VISUAL ACUITY REDUCED 8 0.0002
903 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
904 DERMATITIS 5 0.0002
905 EYE PRURITUS 8 0.0002
906 ERECTILE DYSFUNCTION 6 0.0002
907 LYMPHADENOPATHY 8 0.0002
908 ORAL PAIN 5 0.0002
909 PSORIATIC ARTHROPATHY 9 0.0002
910 BLADDER CANCER 13 0.0002
911 NEUTROPENIA 30 0.0002
912 MOOD ALTERED 6 0.0002
913 WHEEZING 13 0.0002
914 HAEMATOCHEZIA 12 0.0002
915 RESPIRATORY DISTRESS 6 0.0002
916 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
917 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
918 FLATULENCE 12 0.0002
919 GASTRIC ULCER 4 0.0002
920 FEELING JITTERY 4 0.0002
921 BRADYCARDIA 11 0.0002
922 ERUCTATION 4 0.0002
923 NEEDLE ISSUE 6 0.0002
924 LIVER INJURY 5 0.0002
925 ENCEPHALOPATHY 5 0.0002
926 HALLUCINATION 15 0.0002
927 GASTRIC CANCER 5 0.0002
928 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
929 EPILEPSY 6 0.0002
930 ARRHYTHMIA 9 0.0002
931 DYSGEUSIA 14 0.0002
932 DISEASE PROGRESSION 22 0.0002
933 HYPOGLYCAEMIA 9 0.0002
934 DRY MOUTH 15 0.0002
935 PNEUMONITIS 5 0.0002
936 MENTAL STATUS CHANGES 5 0.0002
937 ANGINA PECTORIS 5 0.0002
938 RASH MACULAR 6 0.0002
939 NO ADVERSE EVENT 31 0.0002
940 RENAL CANCER 8 0.0002
941 INTERSTITIAL LUNG DISEASE 8 0.0002
942 HYPERGLYCAEMIA 6 0.0002
943 RESTLESSNESS 6 0.0002
944 AGITATION 12 0.0002
945 INJECTION SITE BRUISING 13 0.0002
946 EMOTIONAL DISTRESS 19 0.0002
947 COLITIS ULCERATIVE 7 0.0002
948 HEPATITIS 4 0.0002
949 THERAPY CESSATION 8 0.0002
950 SURGERY 9 0.0002
951 LIP SWELLING 5 0.0001
952 SKIN DISORDER 5 0.0001
953 ANGER 5 0.0001
954 COMA 7 0.0001
955 MULTIPLE SCLEROSIS 7 0.0001
956 ADVERSE DRUG REACTION 13 0.0001
957 CARDIO-RESPIRATORY ARREST 6 0.0001
958 HYPOXIA 5 0.0001
959 UNDERDOSE 10 0.0001
960 ACUTE MYOCARDIAL INFARCTION 4 0.0001
961 DRY SKIN 18 0.0001
962 DEVICE ISSUE 12 0.0001
963 ECZEMA 7 0.0001
964 CORONARY ARTERY DISEASE 4 0.0001
965 STOMATITIS 8 0.0001
966 INCORRECT DOSE ADMINISTERED 30 0.0001
967 RASH ERYTHEMATOUS 6 0.0001
968 HYPERKALAEMIA 4 0.0001
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
970 SKIN IRRITATION 5 0.0001
971 HYPOKALAEMIA 5 0.0001
972 DRUG INTERACTION 17 0.0001
973 UNEVALUABLE EVENT 8 0.0001
974 FEBRILE NEUTROPENIA 7 0.0001
975 EYE IRRITATION 6 0.0001
976 INJECTION SITE REACTION 7 0.0001
977 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
978 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
979 PRODUCT DOSE OMISSION 6 0.0001
980 HYPONATRAEMIA 5 0.0001
981 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
982 SKIN EXFOLIATION 7 0.0001
983 SUICIDAL IDEATION 7 0.0001
984 PRODUCT STORAGE ERROR 6 0.0001
985 INJECTION SITE PAIN 21 0.0001
986 ACNE 5 0.0001
987 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
989 PRODUCT USE ISSUE 6 0.0000
990 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000